Education
About Us
Working with TipRanks
Follow Us
McKesson Corporation (MCK)
:MCK
MCK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$464.42 - $731.00
Previous CloseN/A
Volume137.88K
Average Volume (3M)997.31K
Market Cap
$89.44B
Enterprise Value$95.53B
Total Cash (Recent Filing)$1.13B
Total Debt (Recent Filing)$9.76B
Price to Earnings (P/E)27.8
Beta0.28
Next Earnings
Jul 30, 2025EPS Estimate
8.28Last Dividend Ex-Date
Jun 02, 2025Dividend Yield0.38%
Share Statistics
EPS (TTM)10.12
Shares Outstanding125,112,236
10 Day Avg. Volume725,672
30 Day Avg. Volume997,308
Financial Highlights & Ratios
PEG Ratio2.37
Price to Book (P/B)-28.33
Price to Sales (P/S)0.00
P/FCF Ratio43.05
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue0.07
Enterprise Value/Gross Profit7.38
Enterprise Value/Ebitda4.68
Forecast
1Y Price Target
$768.17Price Target Upside8.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
McKesson News
Bulls Say, Bears Say
Bulls Say
Earnings GrowthAnalyst remains positive on McKesson Corporation following the guidance for FY26 adjusted EPS growth.
Strategic Portfolio UpdateManagement believes the strategic portfolio update will position the company to focus better on strategic growth areas and more effectively deploy capital.
ValuationThe price target for McKesson Corporation has been raised, suggesting that shares can trade at a higher valuation based on a discounted cash flow analysis.
Bears Say
Drug Pricing RegulationThe potential enactment of a most-favored nation (MFN) drug pricing does create a potential overhang on the space.
Product And Pricing UncertaintyThere are limited details about the number of products that would be impacted, countries that would be included in the reference basket, impact on new product launches, which payment channels are included, and how pricing would be implemented.
Ownership Overview
0.06% Insiders
23.42% Mutual Funds
16.54% Other Institutional Investors
38.75% Public Companies and Individual Investors
MCK FAQ
What was McKesson Corporation’s price range in the past 12 months?
McKesson Corporation lowest stock price was $464.42 and its highest was $731.00 in the past 12 months.
What is McKesson Corporation’s market cap?
McKesson Corporation’s market cap is $89.44B.
When is McKesson Corporation’s upcoming earnings report date?
McKesson Corporation’s upcoming earnings report date is Jul 30, 2025 which is in 55 days.
How were McKesson Corporation’s earnings last quarter?
McKesson Corporation released its earnings results on May 08, 2025. The company reported $10.12 earnings per share for the quarter, beating the consensus estimate of $9.827 by $0.293.
Is McKesson Corporation overvalued?
According to Wall Street analysts McKesson Corporation’s price is currently Undervalued.
Does McKesson Corporation pay dividends?
McKesson Corporation pays a Quarterly dividend of $2.836 which represents an annual dividend yield of 0.38%. See more information on McKesson Corporation dividends here
What is McKesson Corporation’s EPS estimate?
McKesson Corporation’s EPS estimate is 8.28.
How many shares outstanding does McKesson Corporation have?
McKesson Corporation has 125,112,236 shares outstanding.
What happened to McKesson Corporation’s price movement after its last earnings report?
McKesson Corporation reported an EPS of $10.12 in its last earnings report, beating expectations of $9.827. Following the earnings report the stock price went up 0.466%.
Which hedge fund is a major shareholder of McKesson Corporation?
Currently, no hedge funds are holding shares in MCK
McKesson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$768.17 (8.28% Upside)
$768.17 (8.28% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 300.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.21%
12-Months-Change
Fundamentals
Return on Equity
51.23%
Trailing 12-Months
Asset Growth
11.41%
Trailing 12-Months
Company Description
McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
MCK Company Deck
MCK Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with record revenue and EPS growth, strategic acquisitions, and robust shareholder returns. However, there are challenges related to business divestitures, regulatory uncertainties, and the planned separation of the medical surgical segment.Read More>MCK Revenue Breakdown
90.22% U.S. Pharmaceutical
4.57% International
3.66% Medical-Surgical Solutions
1.54% Prescription Technology Solutions
MCK Stock 12 Month Forecast
Average Price Target
$768.17
▲(8.28%Upside)